Cargando…
Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study
BACKGROUND: We previously reported that high body weight was a risk factor affecting the onset of anti-epidermal growth factor receptor (EGFR) antibody drug-induced acneiform rash. The current study investigated the relationship between risk factors for anti-EGFR antibody drug-induced acneiform rash...
Autores principales: | Takahashi, Hiroaki, Yaegashi, Yukiko, Saito, Yoko, Nihei, Satoru, Tairabune, Tomohiko, Ujiie, Haruki, Asaka, Junichi, Kudo, Kenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434966/ https://www.ncbi.nlm.nih.gov/pubmed/36045384 http://dx.doi.org/10.1186/s40780-022-00253-y |
Ejemplares similares
-
Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In Vitro
por: Nihei, Satoru, et al.
Publicado: (2021) -
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2013) -
Panitumumab-Induced Acneiform Rash in a Patient with Metastatic Colon Adenocarcinoma
por: Martins-Filho, Paulo Ricardo Saquete, et al.
Publicado: (2013) -
Treatment of Acneiform Rash Due to Bromide of Potassium, While Continuing the Remedy
Publicado: (1882) -
Reducing Acneiform Rash Induced by EGFR Inhibitors With Honeysuckle Therapy: A Prospective, Randomized, Controlled Study
por: Liu, Zhen, et al.
Publicado: (2022)